摘要
背景:活化小胶质细胞通过产生多种促炎介质,包括对神经元和少突胶质细胞有毒的肿瘤坏死因子-α(TNF-α),白细胞介素-1β(IL-1β)和一氧化氮(NO),在神经退行性疾病中发挥关键作用。 。 方法:鉴于上述情况,抑制小胶质细胞介导的神经炎症被认为是神经退行性疾病的治疗策略。据报道,几种潜在的中草药提取物对特异性靶向活化的小胶质细胞的神经退行性疾病发挥神经保护作用。在这方面,酚类葡萄糖苷天麻素是中草药天麻的主要成分,在当地社区广泛产生,通过抑制神经毒性促炎介质显示出潜在的神经保护作用。 结果:在这里,我们首先回顾激活的小胶质细胞在不同脑疾病中的作用。然后考虑天麻素对活化的小胶质细胞的影响。我们已经将天麻素鉴定为推定的治疗剂,因为已发现其可抑制小胶质细胞活化,从而改善神经炎症。更重要的是,天麻素下调肾素血管紧张素系统(RAS)的表达和促炎介质的产生。值得注意的是,天麻素促进Sirtuin 3(Sirt3)上调和烟酰胺腺嘌呤二核苷酸磷酸氧化酶-2(NOX-2)下调后激活的小胶质细胞中由AT1或AT2受体介导的血管紧张素II受体亚型,表明可能的分子RAS和Sirt3生存基因之间的联系。 结论:本综述总结了天麻素作用于活化小胶质细胞和其他草药化合物的有益作用。它在神经保护方面的功效与中国一些常见的草药产品一致。
关键词: 天麻素,活化小胶质细胞,肾素血管紧张素系统-Sirtuin 3信号,抗炎,神经保护,草药化合物。
Current Medicinal Chemistry
Title:Herbal Compounds with Special Reference to Gastrodin as Potential Therapeutic Agents for Microglia Mediated Neuroinflammation
Volume: 25 Issue: 42
关键词: 天麻素,活化小胶质细胞,肾素血管紧张素系统-Sirtuin 3信号,抗炎,神经保护,草药化合物。
摘要: Background: Activated microglia play a pivotal role neurodegenerative diseases by producing a variety of proinflammatory mediators including tumor necrosis factor-alpha (TNF-α), interleukin- 1beta (IL-1β) and nitric oxide (NO) that are toxic to neurons and oligodendrocytes.
Methods: In view of the above, suppression of microglia mediated neuroinflammation is deemed a therapeutic strategy for neurodegenerative diseases. Several potential Chinese herbal extracts have been reported to exert neuroprotective effects against neurodegenerative diseases targeting specifically at the activated microglia. In this connection, the phenolic glucoside gastrodin, a main constituent of the Chinese herbal medicine Gastrodia rhizoma, produced widely in the local community exhibits potential neuroprotective effects through suppression of neurotoxic proinflammatory mediators.
Results: Here, we first review the roles of activated microglia in different brain diseases. The effects of gastrodin on activated microglia are then considered. We have identified gastrodin as a putative therapeutic agent as it has been found to suppress microglial activation thus ameliorating neuroinflammation. More importantly, gastrodin downregulates the expression of renin angiotensin system (RAS) and production of proinflammatory mediators. Remarkably, gastrodin promotes Sirtuin 3 (Sirt3) up-regulation and nicotinamide adenine dinucleotide phosphate oxidase-2 (NOX-2) down-regulation after ischemichypoxia in activated microglia mediated by AT1 or AT2 receptors which are angiotensin II receptors subtypes, indicating a possible molecular link between RAS and Sirt3 survival genes.
Conclusion: This review summarizes the beneficial effects of gastrodin acting on activated microglia along with other herbal compounds. Its efficacy in neuroprotection is consistent with some common herbal products in China.
Export Options
About this article
Cite this article as:
Herbal Compounds with Special Reference to Gastrodin as Potential Therapeutic Agents for Microglia Mediated Neuroinflammation, Current Medicinal Chemistry 2018; 25 (42) . https://dx.doi.org/10.2174/0929867325666180214123929
DOI https://dx.doi.org/10.2174/0929867325666180214123929 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Cellular Immunotherapy for Neuroblastoma: A Review of Current Vaccine and Adoptive T Cell Therapeutics
Current Pharmaceutical Design Invasive Aspergillosis in Children and Adolescents
Current Pharmaceutical Design Medicinal and Beneficial Health Applications of Tinospora cordifolia (Guduchi): A Miraculous Herb Countering Various Diseases/Disorders and its Immunomodulatory Effects
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Assessing the Serum Levels of Ferritin and Selenium in three Important Infections of Childhood, Compared to a Control Group
Current Nutrition & Food Science Alcohol Addiction: A Molecular Biology Perspective
Current Medicinal Chemistry Safety of Cabergoline in the Management of Pituitary Prolactin-Induced Symptoms with Patients Treated with Atypical Neuroleptics
Current Drug Safety Recent Advances of Kinesin Motor Inhibitors and their Clinical Progress
Reviews on Recent Clinical Trials Genetic Predisposition to Neonatal Tumors
Current Pediatric Reviews Relevance of Pharmacokinetic and Pharmacodynamic Modeling to Clinical Care of Critically Ill Patients
Current Pharmaceutical Biotechnology Pentoxifylline Use in Dermatology
Inflammation & Allergy - Drug Targets (Discontinued) Metabolic Control of Glia-Mediated Neuroinflammation
Current Alzheimer Research Kinase Inhibitors in Multitargeted Cancer Therapy
Current Medicinal Chemistry A Systematic Review on Levosimendan in Paediatric Patients
Current Vascular Pharmacology Adenovirus Mediated Herpes Simplex Virus-Thymidine Kinase/Ganciclovir Gene Therapy for Resectable Malignant Glioma
Current Gene Therapy Clinical and Pharmacological Aspects of Inflammatory Demyelinating Diseases in Childhood: An Update
Current Neuropharmacology Calcium Metabolism and Oxidative Stress in Bone Fractures: Role of Antioxidants
Current Drug Metabolism Neurotrophins Role in Depression Neurobiology: A Review of Basic and Clinical Evidence
Current Neuropharmacology Gene Therapy for Lysosomal Storage Diseases: Progress, Challenges and Future Prospects
Current Pharmaceutical Design Osteogenic Differentiation of Orofacial Tissue-Derived Mesenchymal Stem Cells- A Review
Current Tissue Engineering (Discontinued) Prevention and Therapy of Prostate Cancer: An Update on Alternatives for Treatment and Future Perspectives
Current Drug Therapy